JUPITER, FL – July 2025 – Jupiter Neurosciences, primarily known for its robust pharmaceutical pipeline, has announced its strategic entry into the consumer wellness sector with the launch of Nugevia GLO.
Unveiled in early July, following late June announcements, Nugevia GLO is positioned as a premium “beauty-from-within” supplement designed to support skin health at a cellular level.
This new offering represents a significant expansion for Jupiter Neurosciences, leveraging its scientific expertise to tap into the growing demand for ingestible beauty solutions. Nugevia GLO is formulated to enhance skin hydration, bolster cellular defense, and maintain collagen integrity, key factors for a youthful and radiant complexion.
At the core of Nugevia GLO’s efficacy are its clinically validated technologies: Jotrol, a proprietary resveratrol delivery system, and NovaSol Astaxanthin. These advanced ingredients are selected for their powerful antioxidant properties and their ability to address common signs of skin aging from within the body.
“With Nugevia GLO, we’re taking our proprietary science to a broader audience,” said Christer Rosén, Chairman and CEO of Jupiter Neurosciences. “GLO is not just another beauty supplement—it’s a clinically grounded formulation that enhances skin vitality by working at the cellular level. We’re unlocking a high-growth vertical in the $8 trillion longevity market while continuing to advance our pharmaceutical pipeline.”